OpenAI’s new Health in ChatGPT feature for US users can connect to Apple Health and supported medical records, putting sensitive health information inside a conversational AI layer that deserves close privacy scrutiny.
When health questions move from clinics to search bars, apps, wearables, and chatbots, speed can outpace verification and turn private concerns into data and decision-making risks.
Digital longevity promises earlier diagnosis and longer independence, but the real challenge is making continuous health data useful without turning care into constant surveillance.
A major federal push links artificial intelligence to chronic disease research and drug discovery, but the hardest part is not the model - it is the security, governance, and validation of the health data behind it.
The EU court’s C-474/24 ruling shows why context, not just labels, can decide whether an online record becomes sensitive health information.
A social engineering compromise involving employee accounts shows how identity abuse, not malware, can turn sensitive health data into a high-stakes security question.
EHDS pushes secondary use of health data into a new rulebook, and the real tension is how to share information for research without blurring the lines around ownership, control, and value.
The move to bring non-accredited private outpatient clinics into FSE 2.0 is chiefly a compliance-and-integration challenge, but it also raises the stakes for document integrity, selective disclosure, and privacy logging.
A new Italian health-data project is trying to do what Europe has struggled to achieve for years: make clinical records usable for AI research while keeping privacy risk under control.
Partnered Health has confirmed a cyber incident involving patient information across part of its clinic network, underscoring how quickly access-control failures can become privacy events.
Blockchain can strengthen health-data integrity and drug traceability, but in healthcare the hardest security problem is not the ledger - it is how to keep sensitive records governed, interoperable, and legally private.
A new public investment in digital health is aimed at remote monitoring, telecare, and shared medical imaging, but the real challenge will be keeping data governance and access controls aligned with the pace of deployment.
The Ecosistema dei Dati Sanitari is meant to make clinical information more structured and interoperable, but the real question is whether its rollout can be measured clearly enough to trust.
Inertial wearables are pushing biomechanical analysis out of specialized labs and into everyday medicine, where rehabilitation, sports care, and long-term monitoring depend on cleaner data and better interpretation.
Medtronic’s disclosure shows how a cyber incident can put sensitive health data at risk even when products, patients, and day-to-day operations are reported to remain unaffected.
Italy’s privacy watchdog is using its annual review to frame artificial intelligence, data geopolitics, and digital governance as one connected policy problem.
The EU’s health-data and AI rules are turning model quality into a question of provenance, access control, and accountability, not just software performance.
Electric mobility is pushing vehicle data from a support function to a core asset, forcing insurers, fleets, OEMs, and technology providers to rethink how they collect, interpret, and govern telematics.
New EDPB guidance makes room for broad consent in scientific research, yet the real test is whether secondary use of personal and health data can be governed with discipline.
A healthcare design debate is really a systems debate: if care must follow the patient, then health data, workflow software, and AI governance have to move together.